\documentclass[reqno]{amsart}
\usepackage{hyperref}
\usepackage{graphicx}

\AtBeginDocument{{\noindent\small
\emph{Electronic Journal of Differential Equations},
Vol. 2012 (2012), No. 81, pp. 1--22.\newline
ISSN: 1072-6691. URL: http://ejde.math.txstate.edu or http://ejde.math.unt.edu
\newline ftp ejde.math.txstate.edu}
\thanks{\copyright 2012 Texas State University - San Marcos.}
\vspace{9mm}}

\begin{document}
\title[\hfilneg EJDE-2012/81\hfil Application of optimal control]
{Application of optimal control to the epidemiology of malaria}

\author[F. B. Agusto, N.  Marcus, K. O. Okosun\hfil EJDE-2012/81\hfilneg]
{Folashade B. Agusto, Nizar Marcus, Kazeem O. Okosun }  % in alphabetical order

\address{Folashade B. Agusto \newline
Department of Mathematics and Statistics, Austin Peay State University,
 Clarksville, Tennessee 37044, USA}
\email{fbagusto@gmail.com}

\address{Nizar Marcus \newline
 Department of Mathematics and Applied Mathematics,
 University of  the Western Cape, South Africa}
\email{nmarcus@uwc.ac.za}

\address{Kazeem O. Okosun \newline
Department of Mathematics, Vaal University of Technology,
Private Bag X021, Vanderbijlpark, 1900, South Africa}
\email{kazeemoare@gmail.com}


\thanks{Submitted July 2, 2010. Published May 22, 2012.}
\subjclass[2000]{92B05, 93A30, 93C15}
\keywords{Malaria; optimal control; insecticide treated bed nets;
\hfill\break\indent  mosquito insecticide}

\begin{abstract}
 Malaria is a deadly disease transmitted to humans through the bite of
 infected female mosquitoes. In this paper a deterministic system of
 differential equations is presented and studied for the transmission
 of malaria. Then optimal control theory is applied to investigate optimal
 strategies for controlling the spread of malaria disease using treatment,
 insecticide treated bed nets and spray of mosquito insecticide as the system
 control variables. The  possible impact of using combinations of the three
 controls either one at a time or two at a time on the spread of the disease
 is also examined.
\end{abstract}

\maketitle
\numberwithin{equation}{section}
\newtheorem{theorem}{Theorem}[section]
\newtheorem{lemma}[theorem]{Lemma}
\allowdisplaybreaks

\section{Introduction}

Malaria is a common and serious disease. It is reported that the incidence 
of malaria in the world may be in the order of 300 million clinical cases each year. 
Malaria mortality is estimated at almost 2 million deaths worldwide per year. 
The vast numbers of malaria deaths occur among young children in Africa, 
especially in remote rural areas. In addition, an estimated over 2 billion 
people are at risk of infection, no vaccines are available for the disease 
\cite {MAL, WHO}.

Malaria is transmitted to humans through the bite of an infected female 
Anopheles mosquito, following the successful sporozoite inoculation, 
\emph{plasmodium falciparum} is usually first detected 7-11 days. 
This is followed after few days of the bites, by clinical symptoms such
 as sweats, shills, pains, and fever. Mosquitoes on the other hand acquire 
infection from infected human after a blood meal. Although malaria is 
life-threatening it is still preventable and curable if the infected 
individual seek treatment early. Prevention is usually by the use of 
insecticide treated bed nets and spraying of insecticide but according
 to the World Health Organization position statement on insecticide 
treated mosquito nets \cite{WHO3}, the insecticide treated bed nets(ITNs), 
long-lasting insecticide nets (LLINs), indoor residual spraying (IRS),
 and the other main method of malaria vector control, may not be sufficiently 
effective alone to achieve and maintain interruption of transmission of malaria, 
particularly in holo-endemic areas of Africa.

Many studies have been carried out to quantify the impact of malaria 
infection in humans \cite{BRW,Green,KWM,MAC,ROSS,DLS}. Many of these
 studies focuses only on the transmission of the disease in human and 
the vector populations but recently, Chiyaka et.al \cite{chi} formulated 
a deterministic system of differential equations with two latent periods 
in the non-constant host and vector populations in order to theoretically
 assess the potential impact of personal protection, treatment and possible 
vaccination strategies on the transmission dynamics of malaria. Blayneh et al 
\cite{KYH}, used a time dependent model to study the effects of prevention 
and treatment on malaria, similarly Okosun \cite{oko} used a time dependent
 model to study the impact  of a possible vaccination with treatment strategies
 in controlling the spread of malaria in a model that includes treatment and 
vaccination with waning immunity. Thus, following the WHO position statement
 \cite{WHO3} it is instructive to carry out modeling studies to determine 
the impact of various combinations of control strategies on the transmission 
dynamics of malaria. In this paper, we use treatment of symptomatic individuals, 
personal protection and the straying of insecticide as control measures and then 
consider this time dependent control measures using optimal control theory. 
Time dependent control strategies have been applied for the studies of HIV/AIDS 
disease, Tuberculosis, Influenza and SARS
 \cite{ABM, Agu, CEC,  KARRA,Ki, SUPS,van, XIE}. Optimal control theory has been 
applied to models with vector-borne diseases \cite{KYH,rafi,Tho, WICK}.

Our goal is to develop mathematical model for human-vector interactions with 
control strategies, with the aim of investigating the role of personal protection, 
treatment and spraying of insecticides in malaria transmission, in line with 
concerns raised WHO \cite{WHO3}; in order to determine optimal control
 strategies with various combinations of the control measures for controlling 
the spread of malaria transmission. The paper is organized as follows: 
in Section \ref{form}, we give the description of the human-vector model, 
stating the assumptions and definitions of the various parameters of the model.
 The analysis of the equilibrium points are discussed in Sections \ref{dfe} 
and \ref{stab}. In Section \ref{cont}, we state the control problem as well
 as the objective functional to be minimized, we then apply the Pontryagin's
 Maximum Principle to find the necessary conditions for the optimal control.
 In Sections \ref{num}, we show the simulation results to illustrate the population
dynamics with preventative measures and treatment as controls.

\section{Model formulation} \label{form}

The model sub-divides the total human population at time t, denoted by $N_h(t)$, 
into the following sub-populations of  susceptible individuals $(S_h(t))$,  
those exposed to malaria parasite $(E_h(t))$, individuals with malaria 
symptoms $(I_h(t))$, partially immune human $(R_h(t))$. 
So that 
$$
N_h(t) = S_h(t) + E_h(t) + I_h(t)+ R_h(t).
$$

The total vector (mosquito) population at time $t$, denoted by $N_v(t)$, 
is sub-divided into susceptible mosquitoes $(S_v(t))$, mosquitoes exposed 
to the malaria parasite $(E_v(t))$ and infectious mosquitoes$(I_v(t))$. 
Thus,  
$$
N_v(t) = S_v(t) + E_v(t) + I_v(t).
$$

It is assumed that susceptible humans are recruited into the population at a 
constant rate $\Lambda_h$.
Susceptible individuals acquire malaria infection following contact with infectious
 mosquitoes (at a rate $\beta\varepsilon_h\phi$), where $\beta$ is the transmission
probability per bite and $\varepsilon_h$  is the biting rate of mosquitoes,
$\phi$ is contact rate of vector per human per unit time. Susceptible individuals 
infected with malaria are moved to the exposed class $(E_h)$ at the rate 
$\beta\varepsilon_h\phi$ and then progress to the infectious class,
following the development of clinical symptoms (at a rate $\alpha_h$).  
Individuals with malaria symptoms are effectively treated (at a rate $\tau$) 
where ($0\leq\tau\leq 1$). Human  spontaneous recovery rate is given by
$b$, where $0\leq b<\tau$. And individuals infected with malaria suffer 
a disease-induced death (at a rate $\psi$).
Infected individual then progress to the partially immuned  group. 
Upon recovery,  the partially immuned individual losses immunity
(at the rate $\kappa$) and becomes susceptible again.

Susceptible mosquitoes ($S_v$) are generated at the rate $\Lambda_v$ and acquire
 malaria infection
(following effective contacts with  humans infected with malaria) at a rate 
$\lambda\phi\varepsilon_v (I_h + \eta R_h)$, where
$\lambda$ is the probability of a vector getting infected through the infectious 
human and $\varepsilon_v$ is the biting rate of mosquitoes. We assume that humans 
in the $R_h(t)$ class can still transmit the disease, thus, the modification 
parameter $\eta \in [0,1)$ gives the reduced infectivity of the recovered 
individuals \cite{Cov,Ros}. Mosquitoes are assumed to
suffer natural death at a rate $\mu_v$, regardless of their infection status.
 Newly-infected mosquitoes are moved into the exposed class ($E_v$ ), 
and progress to the class of symptomatic mosquitoes ($I_v$) following the
development of symptoms (at a rate $\alpha_v$).

Thus, putting the above formulations and assumptions together gives the 
following human-vector model, given by system of ordinary differential 
equations below as
\begin{equation}
\begin{gathered}
 \frac{dS_h}{dt} = \Lambda_h + \kappa R_h - \beta\varepsilon_h\phi I_vS_h  
 - \mu_h S_h, \\
 \frac{dE_h}{dt} =  \beta\varepsilon_h\phi I_vS_h - (\alpha_h+\mu_h  )E_h,\\
 \frac{dI_h}{dt}  = \alpha_hE_h  -(b + \tau) I_h - ( \psi +  \mu_h)I_h ,\\
 \frac{dR_h}{dt} = (b + \tau) I_h - (\kappa+ \mu_h) R_h,\\ 
 \frac{dS_v}{dt}  = \Lambda_v -  \lambda\phi\varepsilon_v(I_h 
 + \eta R_h) S_v -  \mu_v S_v,\\
 \frac{dE_v}{dt} =  \lambda\phi\varepsilon_v(I_h + \eta R_h)S_v 
 - (\alpha_v +\mu_v) E_v,\\
 \frac{dI_v}{dt} = \alpha_vE_v  - \mu_v I_v,
\end{gathered} \label{eM13}
\end{equation}
The associated model variables and parameters are described in 
Table \ref{p1}.

\subsection{Basic properties of the malaria model}
\subsubsection{Positivity and boundedness of solutions}\label{Pos}

For the malaria transmission model \eqref{eM13} to be epidemiologically
meaningful, it is important to prove that all its state  variables
are non-negative for all time. In other words, solutions of the
model system \eqref{eM13} with non-negative initial data will remain
non-negative for all time $t > 0$.

\begin{theorem} \label{thm0}
Let the initial data $S_h(0) \geq 0$, $E_h(0)\geq 0$,
$I_h(0) \geq 0$, $R_h(0) \geq 0$, $S_v(0) \geq 0$, $E_v(0)\geq 0$, 
$I_v(0) \geq 0$. Then the solutions $(S_h,  E_h, I_h,
R_h$, $S_v, E_v, I_v)$ of the malaria model \eqref{eM13} are
non-negative for all $t > 0$. Furthermore
$$
\limsup_{t\to\infty} N_h(t)\leq\frac{\Lambda_h}{\mu_h},\quad
\limsup_{t\to\infty} N_v(t)\leq\frac{\Lambda_v}{\mu_v},
$$
with
$N_h = S_h+ E_h+ I_h+R_h$ and $N_v = S_v+E_v+I_v$.
\end{theorem}

\begin{proof}
Let $t_1=\sup \{t>0:S_h(t)>0,E_h(t)>0,I_h(t)>0,R_h(t)>0,
S_v(t)>0,I_v(t)>0,E_v(t)>0\}$.
Since $S_h(0)>0,E_h(0)>0,I_h(0)>0,R_h(0)>0,S_v(0)>0,E_v(0)>0,I_v(0)>0
$, then, $t_1>0$. If $t_1<\infty $ , then $S_h$, $E_h$, $I_h$, 
$R_h$, $S_v$, $E_v$ or $I_v$ is equal to zero at $t_1$. 
It follows from the first equation of the system \eqref{eM13},
that
$$
\frac{dS_h}{dt} = \Lambda_h - \beta\varepsilon_h\phi I_vS_h - \mu_h S_h + \kappa R_h
$$
Thus,
$$
\frac{d}{dt}\big\{S_h(t) \exp[(\beta\varepsilon_h\phi I_v + \mu_h )t] \big\}
= (\Lambda_h+ \kappa R_h)\exp [ (\beta\varepsilon_h\phi I_v + \mu_h )t]
$$
Hence,
$$S_h(t_1)\exp[(\beta\varepsilon_h\phi I_v + \mu_h )t ]
-S_h(0)= \int^{t_1}_0(\Lambda_h+ \kappa R_h)
\exp [ (\beta\varepsilon_h\phi I_v + \mu_h )p]dp
$$
so that

\begin{align*}
S_h(t_1) &= S_h(0)~ exp[-(\beta\varepsilon_h\phi I_v + \mu_h )t_1 ]
 +\exp[-(\beta\varepsilon_h\phi I_v + \mu_h )t_1]\\
&\quad\times \int^{t_1}_0(\Lambda_h+ \kappa R_h)\exp 
[ (\beta\varepsilon_h\phi I_v + \mu_h )p ]dp>0.
\end{align*}
and
\begin{align*}
R_h(t_1)&=R_h(0)\exp[-(\mu_h + \kappa)t_1]
  + \exp[(\mu_h + \kappa)t_1]\int^{t_1}_0 (b+\tau) I_h 
\exp[(\mu_h + \kappa)p ]dp\\
&>0.
\end{align*}
It can similarly be shown that $ E_h > 0$, $I_h > 0$, $S_v > 0$, $E_v > 0$ and 
$I_v > 0$ for all $t>0$. For the
second part of the proof, it should be noted that
 $0<I_h(t)\leq N_h(t)$ and $0<I_v(t)\leq N_v(t)$.

 Adding the first four equations and the last three
 equations of the model \eqref{eM13} gives
\begin{equation} \label{eDW}
\begin{gathered}
 \frac{dN_h(t)}{dt}=\Lambda_h -\mu_hN_h(t)-\psi I_h(t),\\
 \frac{dN_v(t)}{dt}=\Lambda_v -\mu_vN_v(t).
\end{gathered}
\end{equation}
Thus,
\begin{gather*}
 \Lambda_h -( \mu_h+\psi)N_h(t) \leq \frac{dN_h(t)}{dt}\leq \Lambda_h -\mu_hN_h(t),\\
 \Lambda_v -\mu_vN_v(t) \leq
\frac{dN_v(t)}{dt}\leq \Lambda_v -\mu_vN_v(t).
\end{gather*}
Hence, respectively,
$$
\frac{\Lambda_h}{ \mu_h+\psi} \leq \liminf_{t\to\infty}N_h(t)
\leq \limsup_{t\to\infty}N_h(t)\leq \frac{\Lambda_h}{\mu_h},
$$
and
$$
\frac{\Lambda_v}{\mu_v} \leq \liminf_{t\to\infty}N_v(t)
\leq \limsup_{t\to\infty}N_v(t)\leq \frac{\Lambda_v}{\mu_v},
$$
as required.
\end{proof}

\subsubsection{Invariant regions}\label{reg}

The malaria model \eqref{eM13} will be analyzed in a
biologically-feasible region as follows. 
The system \eqref{eM13} is split into two parts, namely the human 
population ($N_h$; with $N_h = S_h+ E_h+ I_h+R_h$) and
the vector population ($N_v$; with $N_v = S_v+ E_v+I_v$).
Consider the  feasible region
$$
\mathcal{D}= \mathcal{D}_h\cup \mathcal{D}_v \subset
 \mathbb{R}^4_+\times \mathbb{R}^3_+,
$$
with
\begin{gather*}
\mathcal{D}_h = \{(S_h,E_h,I_h,R_h)\in \mathbb{R}^4_+: S_h+ E_h+ I_h+R_h 
\leq \frac{\Lambda_h}{\mu_h} \}, \\
\mathcal{D}_v = \{(S_v,E_v,I_v)\in \mathbb{R}^3_+: S_v+ E_v+ I_v 
\leq \frac{\Lambda_v}{\mu_v}\}
\end{gather*}
The following steps are done to establish the positive
invariance of $\mathcal{D}$ (i.e., solutions in $\mathcal{D}$ remain in
$\mathcal{D}$ for all $t>0$). The rate of change of the humans
and mosquitoes populations is given in equation \eqref{eDW}, it follows that
\begin{equation} \label{e3}
\begin{gathered}
 \frac{dN_h(t)}{dt}\leq \Lambda_h -\mu_hN_h(t),\\
 \frac{dN_v(t)}{dt}\leq \Lambda_v -\mu_vN_v(t).
\end{gathered}
\end{equation}
A standard comparison theorem \cite{Lak} can then be used to show
that 
$N_h(t)\leq N_h(0)e^{-\mu_ht}+\frac{\Lambda_h}{\mu_h}(1-e^{-\mu_ht})$ 
and
$N_v(t)\leq N_v(0)e^{-\mu_vt}+\frac{\Lambda_v}{\mu_v}(1-e^{-\mu_vt})$. 
In particular, $N_h(t)\leq\frac{\Lambda_h}{\mu_h}$ and
$N_v(t)\leq\frac{\Lambda_v}{\mu_v}$ if
$N_h(0)\leq\frac{\Lambda_h}{\mu_h}$ and
$N_v(0)\leq\frac{\Lambda_v}{\mu_v}$ respectively. Thus, the region
$\mathcal{D}$ is positively-invariant. Hence, it is sufficient to
consider the dynamics of the flow generated by \eqref{eM13} in $\mathcal{D}$. 
In this region, the model can be considered  as been
epidemiologically and mathematically well-posed \cite{Het}. Thus,
every solution of the basic model \eqref{eM13} with initial
conditions in $\mathcal{D}$ remains in $\mathcal{D}$ for all $t > 0$.
Therefore, the $\omega$-limit sets of the system \eqref{eM13} are
contained in $\mathcal{D}$. This result is summarized below.

\begin{lemma} \label{lem1}
The region $\mathcal{D}= \mathcal{D}_h\cup \mathcal{D}_v \subset 
\mathbb{R}^4_+\times \mathbb{R}^3_+$ is positively-invariant for the
 basic model \eqref{eM13} with non-negative initial conditions 
in $\mathbb{R}^7_+$ 
\end{lemma}

\subsection{Stability of the disease-free equilibrium (DFE)}  \label{dfe}

The malaria model \eqref{eM13} has a DFE, obtained by
setting the right-hand sides of the equations in the model to zero,
given by
$$ \mathcal{E}_0 = (S^*_h,E^*_h,I^*_h,R^*_h,S^*_v,E^*_v,I^*_v) 
= \Big(\frac{\Lambda_h}{ \mu_h},0,0,0,\frac{\Lambda_v}{\mu_v},0,0\Big).
$$
The linear stability of $\mathcal{E}_0$ can be established using the
next generation operator method \cite{van} on the system \eqref{eM13}, 
the matrices $F$ and $V,$ for the new
infection terms and the remaining transfer terms, are, respectively, given by
\begin{gather*}
F=\begin{pmatrix}
 0&0 &0 & 0 &\beta\varepsilon_h\phi S^*_h\\
0 & 0 & 0 &0 & 0\\
0 & 0 & 0 &0 & 0\\
0&\lambda\varepsilon_v\phi S^*_v  &\lambda\varepsilon_v\phi\eta S^*_v  &0 &0 \\
 0 & 0 & 0 &0 & 0
\end{pmatrix},
\\
V=\begin{pmatrix}
 k_1& 0 & 0 & 0 &0\\
-\alpha_1 & k_2 & 0 &0 &  0\\
0& -(b+\tau) & k_3 &0 &  0 \\
0&0 &  0 & k_4 & 0  \\
 0 &0 &  0 & -\alpha_2 & \mu_v
\end{pmatrix},
\end{gather*}
where $k_1= \alpha_h+\mu_h$, $k_2=b+\tau+\psi+\mu_h$,
$k_3= \kappa+\mu_h$, $k_4= \alpha_v+\mu_v$.

It follows that the reproduction number
of the malaria system \eqref{eM13}, denoted by $\mathcal{R}_0$, is
\begin{equation}
\mathcal{R}_0 = \sqrt{\frac{\alpha_1\alpha_2\lambda \beta[k_3 
+\eta(b+\tau)]\phi^2\epsilon_h\varepsilon_vS^*_hS^*_v}{k_3 k_4 k_2 k_1\mu_v}},
\label{R1}
\end{equation}
Further, using \cite[Theorem 2]{van}, the following result is established.


\begin{theorem} \label{thm1}
The DFE of the model \eqref{eM13}, given by $\mathcal{R}_{0}$, is locally 
asymptotically stable (LAS) if $\mathcal{R}_0 < 1$, and unstable if
 $\mathcal{R}_0 > 1$.
\end{theorem}


\section{Existence of endemic equilibrium point (EEP)}  \label{stab}

Next conditions for the existence of endemic equilibria for the 
model \eqref{eM13} is explored.
Let
$$ \mathcal{E}_1 = \big(S^{**}_h,E^{**}_h,I^{**}_h,R^{**}_h,S^{**}_v,E^{**}_v,
I^{**}_v\big),
$$
be the arbitrary endemic equilibrium of model \eqref{eM13}, in which at least 
one of the infected components of the model is non-zero.
Let
\begin{gather}
\lambda^{**}_h =  \beta\phi\varepsilon_hI_v , \label{eLH} \\
\lambda^{**}_v =  \lambda\phi\varepsilon_v (I_h + \eta R_h) \label{eLV}
\end{gather}
be the force of infection in humans and in the vector. 
Setting the right-hand sides of the equations in \eqref{eM13} to 
zero gives the following expressions 
(in terms of $\lambda^{**}_h$ and $\lambda^{**}_v$)
\begin{equation} \label{eEEP}
\begin{gathered}
 S^{**}_h = \frac{\Lambda^{**}_h k_1 k_2 k_3}{(\lambda_h +\mu_h ) k_1 k_2 k_3
 -\kappa\lambda^{**}_h \alpha_h (b+\tau)},\\
 E^{**}_h = \frac{k_2\lambda^{**}_h\Lambda_h k_3}{(\lambda_h +\mu_h ) k_1 k_2 k_3
 -\kappa\lambda^{**}_h \alpha_h (b+\tau)},
 \\
 I^{**}_h = \frac{\lambda^{**}_h\Lambda_h k_3\alpha_1}{(\lambda_h +\mu_h ) k_1 k_2 k_3
 -\kappa\lambda^{**}_h \alpha_h (b+\tau)},\\
 R^{**}_h = \frac{(b+\tau)\lambda^{**}_h\Lambda_h\alpha_1}{(\lambda_h +\mu_h )
 k_1 k_2 k_3 -\kappa\lambda^{**}_h \alpha_h (b+\tau)},
\\
 S^{**}_v = \frac{\Lambda_v }{(\lambda^{**}_v +\mu_v )}, \quad
 E^{**}_v = \frac{\lambda^{**}_v\Lambda_v}{k_4(\lambda^{**}_v +\mu_v ) } ,\quad
I^{**}_v = \frac{\alpha_v\lambda^{**}_v\Lambda_v}{k_4\mu_v(\lambda^{**}_v
+\mu_v )}
\end{gathered}
\end{equation}
Substituting \eqref{eEEP} and \eqref{eLV} into \eqref{eLH}, gives
$a_0 \lambda^{**}_h + b_0=0$,
where
\begin{gather*}
a_0 =  k_4\mu_v \{\lambda\phi\varepsilon_v\Lambda_h\alpha_h [k_3
 +\eta (b+\tau)]+\mu_v [k_3 k_1 k_2 -\kappa\alpha_h (b+\tau)]\} \\
b_0 =  \mu_h\mu_v^2 k_4 k_3 k_1 k_2(1-\mathcal{R}^2_0).
\end{gather*}
The coefficient $a_0$ is always positive, the coefficient $b_0$ is positive
 (negative) if $\mathcal{R}_0$ is less than (greater than) unity.
 Furthermore, there is no positive endemic equilibrium if $b_0\geq 0$.
If $b_0 < 0$, then there is a unique endemic equilibrium
(given by $\lambda_h = b_0/a_0$). This result is summarized below.


\begin{lemma}  \label{lem2}
The model \eqref{eM13} has a unique positive endemic equilibrium whenever
 $\mathcal{R}_0 > 1$,
and no positive endemic equilibrium otherwise.
\end{lemma}

\subsection{Global stability of endemic equilibrium for a special case}

In this section, we investigate the global stability of the endemic equilibrium
 of model \eqref{eM13}, for the special case when $\kappa=0$, that there is no 
lost of immunity.  Using the approach in the proof of Lemma \ref{lem1},
 it can be shown that the region
$$
\tilde{\mathcal{D}}= \tilde{\mathcal{D}}_h \cup \tilde{\mathcal{D}}_v\subset
 \mathbb{R}^4_+\times  \mathbb{R}^3_+,
$$
where
\begin{gather*}
\tilde{\mathcal{D}}_h =   \big\{ (S_h,E_h,I_h,R_h) \subset
 \mathcal{D}_h~\colon S_h \leq S^*_h\big\},
\\
\tilde{\mathcal{D}}_v =   \big\{ (S_v,E_v,I_v) \subset \mathcal{D}_v
: S_v\leq S^*_v\big\}.
\end{gather*}
is positively-invariant for the special case of the model \eqref{eM13} described 
above.  It is convenient to define
$$
\tilde{\mathcal{D}} =\big\{ (S_h,E_h,I_h,R_h,S_v,E_v,I_v) 
\in \mathcal{D}~\colon E_h=I_h=R_h=E_v=I_v=0\big\}.
$$

\begin{theorem} \label{impeep} 
The unique endemic equilibrium, $\tilde{\mathcal{E}}_1$, of the model \eqref{eM13}
 is GAS in $\tilde{\mathcal{D}}\backslash \tilde{\mathcal{D}}_0$ whenever
 $\tilde{\mathcal{R}}_0{_{|_{\kappa=0}}} > 1$.
\end{theorem}

\begin{proof}
Let $\tilde{\mathcal{R}}_0 > 1$, so that the unique endemic equilibrium 
($\tilde{\mathcal{E}}_1$) exists.  Consider the non-linear Lyapunov function
\begin{align*}
\mathcal{F} 
&=   S_h^{**}\Big(\frac{S_h}{S_h^{**}} - \ln \frac{S_h}{S_h^{**}} \Big) 
 +  E_h^{**}\Big(\frac{E_h}{E_h^{**}} - \ln \frac{E_h}{E_h^{**}} \Big)
 +  \frac{k_1}{\alpha_h}I_h^{**}\Big(\frac{I_h}{I_h^{**}} 
  - \ln \frac{I_h}{I_h^{**}}\Big)   \\
&\quad + \frac{k_2k_1}{\alpha_h\gamma}R_h^{**}\Big(\frac{R_h}{R_h^{**}}
   - \ln \frac{R_h}{R_h^{**}}\Big) 
 +   S_v^{**}\Big(\frac{S_v}{S_v^{**}} 
 - \ln \frac{S_v}{S_v^{**}} \Big) 
 +  E_v^{**}\Big(\frac{E_v}{E_v^{**}} - \ln \frac{E_v}{E_v^{**}} \Big) \\
&\quad +  \frac{k_4}{\alpha_v}I_v^{**}\Big(\frac{I_v}{I_v^{**}} 
 - \ln \frac{I_v}{I_v^{**}}\Big) ,
\end{align*}
 where $\gamma = b+\tau$ and the Lyapunov derivative is 
\begin{align*}
\dot{\mathcal{F}} 
&=   \Big(1 - \frac{S_h^{**}}{S_h} \Big)\dot{S_h}  
  +  \Big(1 - \frac{E_h^{**}}{E_h} \Big)\dot{E}_h 
  +  \frac{k_1}{\alpha_h}\Big(1  - \frac{I_h^{**}}{I_h}\Big)\dot{I_h}
  +  \frac{k_2k_1}{\alpha_h\gamma}\Big(1 - \frac{R_h^{**}}{R_h}\Big)\dot{R_h}\\
&\quad +     \Big(1 - \frac{S_v^{**}}{S_v} \Big)\dot{S_v}  
  +  \Big(1 - \frac{E_v^{**}}{E_v} \Big)\dot{E}_v 
  +  \frac{k_4}{\alpha_v}\Big(1  - \frac{I_v^{**}}{I_v}\Big)\dot{I_v}.
\end{align*}
Substituting the expressions for the derivatives in $\dot{\mathcal{F}}$ 
(from \eqref{eM13} with $\kappa=0$) gives
\begin{align*}
\dot{\mathcal{F}}
 &= \Lambda_h - \lambda_hS_h  - \mu_h S_h  -   \frac{S_h^{**}}{S_h} 
  \Big(\Lambda_h - \lambda_hS_h  - \mu_h S_h \Big)\\
 &\quad +  \lambda_hS_h - k_1E_h   -  \frac{E_h^{**}}{E_h}
  \Big(  \lambda_hS_h - k_1E_h \Big)\\
 &\quad +  \frac{k_1}{\alpha_h} \Big(\alpha_hE_h  -k_2I_h\Big)
  - \frac{k_1}{\alpha_h} \frac{I_h^{**}}{I_h}\Big(\alpha_hE_h  -k_2I_h \Big)\\
 &\quad +  \frac{k_2k_1}{\alpha_h\gamma}\Big( \gamma I_h - k_3 R_h\Big)
  - \frac{k_2k_1}{\alpha_h\gamma}\frac{R_h^{**}}{R_h} \Big(\gamma I_h - k_3 R_h\Big)\\
 &\quad +  \Lambda_v - \lambda_v S_v - \mu_v S_v -\frac{S_v^{**}}{S_v}
  \Big( \Lambda_v - \lambda_v S_v -  \mu_v S_v \Big)\\
 &\quad +  \lambda_v S_v -k_4 E_v +  \frac{E_v^{**}}{E_v}
 \Big( \lambda_v S_v -k_4 E_v \Big) \\
 &\quad +   \frac{k_4}{\alpha_v}\Big( \alpha_vE_v - \mu_v I_v \Big)
 +  \frac{k_4}{\alpha_v}\frac{I_v^{**}}{I_v}\Big(\alpha_vE_v - \mu_v I_v\Big).
\end{align*} %\label{eFP}
so that
\begin{equation} \label{eFPF}
\begin{split}
\dot{\mathcal{F}}
&=   \lambda_h S_h^{**}\Big(1-\frac{S_h^{**}}{S_h}\Big)
  + \mu_hS^{**}_h\Big(2-\frac{S_h}{S^{**}_h}-\frac{S^{**}_h}{S_h}\Big)
  + \lambda_hS^{**}_h   - \frac{E^{**}_h}{E_h}\lambda_h S_h  \\
&\quad + k_1 E^{**}_h 
  - k_1\frac{I^{**}_h}{I_h}E_h + \frac{k_2k_1}{\alpha_h}I^{**}_h 
  -\frac{k_2k_1}{\alpha_h}\frac{R^{**}_h}{R_h}I_h 
  + \frac{k_3k_2k_1}{\alpha_h\gamma}R_h -\frac{k_3k_2k_1}{\alpha_h\gamma}R_h  \\
&\quad +   \lambda_v S_v^{**}\Big(1-\frac{S_v^{**}}{S_v}\Big)
  + \mu_vS^{**}_v\Big(2-\frac{S_v}{S^{**}_v}-\frac{S^{**}_v}{S_v}\Big)
  + \lambda_vS^{**}_v\\ 
&\quad - \frac{E^{**}_v}{E_v}\lambda_v S_v + k_4 E^{**}_v - k_4\frac{I^{**}_v}{I_v}E_v
  + \frac{k_4\mu_v}{\alpha_v}I^{**}_v - \frac{k_4\mu_v}{\alpha_v}I_v
\end{split}
\end{equation}
Finally, equation \eqref{eFPF} can be further simplified to give
\begin{equation}
\begin{split}
{\dot{\mathcal{F}}}  
&=   \mu_h S_h^{**} \Big(2- \frac{S_h^{**}}{S_h} -\frac{S_h}{S_h^{**}} \Big) 
  +k_1E_h^{**} \Big( 5 - \frac{S_h^{**}}{S_h}
 - \frac{E_h^{**}}{E_h}- \frac{E_h}{E^{**}_h}\frac{I_h^{**}}{I_h}\\
&\quad - \frac{I_h}{I_h^{**}}\frac{R_h^{**}}{R_h} - \frac{R_h}{R_h^{**}} \Big)
  + \  \mu_v S_v^{**} \Big(2- \frac{S_v^{**}}{S_v} -\frac{S_v}{S_v^{**}} \Big)  \\
&\quad +k_4E_v^{**} \Big( 4 - \frac{S_v^{**}}{S_v}- \frac{E_v^{**}}{E_v}
 - \frac{E_v}{E^{**}_v}\frac{I_v^{**}}{I_v}- \frac{I_v}{I_v^{**}} \Big).
\end{split}\label{eF2}
\end{equation}
 Since the arithmetic mean exceeds the geometric mean, it follows that
 \begin{gather*}
2 -\frac{S_h^{**}}{S_h} -\frac{S_h}{S_h^{**}}  \leq 0,\quad
2 - \frac{S_v^{**}}{S_v} -\frac{S_v}{S_v^{**}}\leq 0, \\
4 - \frac{S_v^{**}}{S_v}- \frac{E_v^{**}}{E_v}
  - \frac{E_v}{E^{**}_v}\frac{I_v^{**}}{I_v}- \frac{I_v}{I_v^{**}}  \leq 0,\\
5 - \frac{S_h^{**}}{S_h}- \frac{E_h^{**}}{E_h}
 - \frac{E_h}{E^{**}_h}\frac{I_h^{**}}{I_h}
 - \frac{I_h}{I_h^{**}}\frac{R_h^{**}}{R_h} - \frac{R_h}{R_h^{**}} \leq 0
 \end{gather*}
Since all the model parameters are non-negative, it follows that
 $\dot{\mathcal{F}}\leq 0 $ for $\tilde{\mathcal{R}}_{0}{_{|_{\kappa=0}}}>1$. 
 Thus, it follows from the LaSalle's Invariance Principle, that every solution 
to the equations in the  model \eqref{eM13} (with initial conditions 
in $\tilde{\mathcal{D}}\backslash \tilde{\mathcal{D}}_0$) approaches the
 EEP ($\tilde{\mathcal{E}}_1$) as $t\to \infty$ whenever 
$\tilde{\mathcal{R}}_{0}{_{|_{\kappa=0}}}>1$.
\end{proof}


\section{Analysis of optimal control}  \label{cont}

We introduce into the model \eqref{eM13}, time dependent preventive ($u_1,u_3$) 
and treatment ($u_2$) efforts as controls to curtail the spread
of malaria. The malaria model \eqref{eM13} becomes
\begin{gather}
 \frac{dS_h}{dt} = \Lambda_h + \kappa R_h - (1-u_1)\beta\varepsilon_h\phi I_vS_h  
 - \mu_h S_h, \notag \\
 \frac{dE_h}{dt} =  (1-u_1)\beta\varepsilon_h\phi I_vS_h - (\alpha_h+\mu_h 
 )E_h, \notag\\
 \frac{dI_h}{dt}  = \alpha_hE_h  -(b + u_2) I_h - ( \psi +  \mu_h)I_h , \notag\\
 \frac{dR_h}{dt} = (b + u_2) I_h - (\kappa+ \mu_h) R_h, 
 \notag\\ 
 \frac{dS_v}{dt}  = \Lambda_v -  (1-u_1)\lambda\varepsilon_v\phi (I_h + \eta R_h) S_v 
 - u_3(1-p)S_v - \mu_v S_v,  
\label{eM12}\\
 \frac{dE_v}{dt} = (1-u_1)\lambda\varepsilon_v\phi  (I_h + \eta R_h) S_v 
 - u_3(1-p)E_v - (\alpha_v +\mu_v) E_v, \notag\\
 \frac{dI_v}{dt} = \alpha_vE_v - u_3(1-p)I_v  - \mu_v I_v. \notag
\end{gather} 
The function $0\leq u_1\leq 1$ represent the control on the use of
mosquitoes treated bed nets for personal protection,
and $0 \leq u_2 \leq a_2$, the control on treatment, where $a_2$ is
the drug efficacy use for treatment. 
The insecticides used for treating bed nets is lethal to the mosquitoes and 
other insects and also repels the mosquitoes, thus, reducing the number that 
attempt to feed on people in the sleeping areas with the nets \cite{CDC,WHO3}. 
However, the mosquitoes can still feed on humans outside this protective areas, 
and so we have included the spraying of insecticide. Thus, each mosquitoes group 
is reduced (at the rate $u_3$ $(1 - p)$), where $(1 - p)$ is the
fraction of vector population reduced and $0 \leq u_3 \leq a_3$, 
is the control function representing spray of insecticide aimed at reducing 
the mosquitoes sub-populations and $a_3$ represent the
insecticide efficacy at reducing the mosquitoes population. 
This is different from what was implemented in \cite{KYH}, where only two 
control measures of personal protection and treatment were used.


With the given objective function 
\begin{equation} 
J(u_1, u_2, u_3) = \int^{t_f}_0[ mI_h + nu_1^2 + cu_2^2 + du_3^2 ]dt \label{eJ} 
\end{equation}
where $t_f$ is the final time and the coefficients $m,n,c,d$  are positive weights
 to balance the factors.
Our goal is to minimize the number of infected humans $I_h(t)$, while minimizing 
the cost of control $u_1(t),~u_2(t),~u_3(t)$. Thus, we seek an optimal control 
$u^*_1, u_2^*, u_3^*$ such that
\begin{equation}
J(u^*_1, u_2^*, u_3^*)=\min_{u_1,u_2,u_3}\{J(u_1,u_2,u_3)|u_1,u_2,u_3\in\mathcal{U}\}
\end{equation}
where the control set 
$$
\mathcal{U}=\{(u_1,u_2,u_3)\mid u_i:[0,t_f]\to [0,1], 
\text{ Lebesgue measurable } i=1,2,3\}.
$$
The term $mI_h$ is the cost of infection while $nu^2_1$, $cu_2^2$ and $du^2_3$ 
are the costs of use of bed nets, treatment efforts and use of insecticides 
respectively.
The necessary conditions that an optimal control must satisfy come from 
the Pontryagin's Maximum Principle \cite{Pon}. This principle converts 
\eqref{eM12}-\eqref{eJ} into a problem of minimizing pointwise a 
Hamiltonian $H$, with respect to $(u_1,u_2,u_3)$
\begin{equation}
\begin{split}
 H&= m I_h+n u^2_1+cu_2^2 +du_3^2 + \lambda_{S_h}\{\Lambda_h
  + \kappa R_h - (1-u_1)\beta\varepsilon_h\phi I_vS_h - \mu_h S_h\}\\
 &\quad + \lambda_{E_h}\{(1-u_1)\beta\varepsilon_h\phi I_vS_h 
 - (\alpha_h+\mu_h  )E_h  \}\\
 &\quad + \lambda_{I_h}\{\alpha_hE_h  -(b + u_2) I_h 
 - ( \psi +  \mu_h)I_h \}\\
 &\quad + \lambda_{R_h}\{(b + u_2) I_h - (\kappa+ \mu_h) R_h \}\\
 &\quad + \lambda_{S_v}\{\Lambda_v -  (1-u_1)\lambda\varepsilon_v\phi 
  (I_h + \eta R_h) S_v - u_3(1-p)S_v - \mu_v S_v \}\\
 &\quad + \lambda_{E_v}\{ (1-u_1)\lambda\varepsilon_v\phi  
 (I_h + \eta R_h) S_v - u_3(1-p)E_v - (\alpha_v +\mu_v) E_v\}\\
 &\quad + \lambda_{I_v}\{\alpha_v2E_v - u_3(1-p)I_v  - \mu_v I_v \}
\end{split}\label{eH}
\end{equation}
where the $\lambda_{S_h}$, $\lambda_{E_h}$, $\lambda_{I_h}$, $\lambda_{R_h}$,
$\lambda_{S_v}$, $\lambda_{E_v}$, $\lambda_{I_v}$ are the adjoint variables or
 co-state variables.
\cite[Corollary 4.1]{Fl} gives the existence of optimal
control due to the convexity of the integrand of $J$ with respect to $u_1,~u_2$
and $u_{3}$, a \textit{priori} boundedness of the state solutions, and the
\textit{Lipschitz} property of the state system with respect to the state
variables. Applying Pontryagin's Maximum Principle \cite{Pon} and the existence 
result for the optimal control from \cite{Fl}, we obtain the following theorem.

\begin{theorem} \label{thm4}
Given an optimal control $u^*_1$, $u^*_2$, $u^*_3$ and solutions 
$S_h^*$, $E_h^*$, $I_h^*$, $R_h^*$, $S_v^*$, $E_v^*$, $I_v^*$ of the
corresponding state system \eqref{eM12} that minimizes $J(u_1,u_2,u_3)$ 
over $\mathcal{U}$. Then there exists adjoint
variables $\lambda_{S_h}$, $\lambda_{E_h}$, $\lambda_{I_h}$, $\lambda_{R_h}$,
$\lambda_{S_v}$, $\lambda_{E_v}$, $\lambda_{I_v}$ satisfying
\begin{equation}
\begin{gathered}
 - \frac{d\lambda_{S_h}}{dt}= -[(1-u_1)\beta\varepsilon_h\phi I_v + \mu_h]
 \lambda_{S_h}  + (1-u_1)\beta\varepsilon_h\phi I_v\lambda_{E_h}  \\
 - \frac{d\lambda_{E_h}}{dt}= -(\mu_h + \alpha_h)\lambda_{E_h} 
 + \alpha_h\lambda_{I_h} \\
 \begin{aligned}
- \frac{d\lambda_{I_h}}{dt}
&=  m - [ (b+u_2)+ (\mu_h + \psi)]\lambda_{I_h} 
 + (b+u_2)\lambda_{R_h} \\
&\quad  + (1-u_1)\lambda\varepsilon_v\phi S_v(\lambda_{E_v} -\lambda_{S_v}) 
\end{aligned}
\\
 - \frac{d\lambda_{R_h}}{dt}= \kappa\lambda_{S_h}  - (\mu_h + \kappa)\lambda_{R_h}
 + (1-u_1)\lambda\varepsilon_v\phi\eta S_v(\lambda_{S_v}-\lambda_{E_v}) 
\\
\begin{aligned}
 - \frac{d\lambda_{S_v}}{dt}&= - [(1-u_1)\lambda\varepsilon_v\phi(I_h+\eta R_h) 
+ u_3(1-p) + \mu_v]\lambda_{S_v}  \\
&\quad + (1-u_1)\lambda\varepsilon_v\phi(I_h+\eta R_h)\lambda_{E_v} 
\end{aligned}\\
 - \frac{d\lambda_{E_v}}{dt}=  -[ u_3(1-p)+ \alpha_v + \mu_v]\lambda_{E_v} 
 + \alpha_v\lambda_{I_v} \\
 - \frac{d\lambda_{I_v}}{dt}=  -(1-u_1)\beta\varepsilon_h\phi S_h\lambda_{S_h} 
 + (1-u_1)\beta\varepsilon_h\phi S_h\lambda_{E_h}  - [u_3(1-p)+  \mu_v ]\lambda_{I_v}
\end{gathered}\label{eA}
\end{equation}
and with transversality conditions
\begin{equation} 
\lambda_{S_h}(t_f)=\lambda_{E_h}(t_f)=~\lambda_{I_h}(t_f)
=\lambda_{R_h}(t_f)=\lambda_{S_v}(t_f)=\lambda_{E_v}(t_f)=\lambda_{I_v}(t_f)=0
\label{eT}
\end{equation}
and  the controls $u_1^*, u_2^*$ and $u_3^*$ satisfy the optimality condition
\begin{equation}
\begin{gathered}
 u^*_1 = \max\Big\{0,\min\Big(1, \frac{ \beta\varepsilon_h\phi I^*_v(\lambda_{E_h} 
- \lambda_{S_h}) S^*_h+ \lambda\varepsilon_v\phi (I^*_h+\eta R^*_h)(\lambda_{E_v} 
- \lambda_{S_v}) S^*_v }{2n}\Big)\Big\}, \\
 u^*_2 = \max\Big\{0,\min\Big(1, \frac{ (\lambda_{I_h}  
 - \lambda_{R_h} )I_h^* }{2c}\Big)\Big\}\\
u^*_3 = \max\Big\{0,\min\Big(1, \frac{  (1-p)(S_v^*\lambda_{S_v} 
+ E_v^*\lambda_{E_v } + I_v^*\lambda_{I_v}  ) }{2d}\Big)\Big\}
 \end{gathered} \label{eC}
\end{equation}
\end{theorem}

\begin{proof}
The differential equations governing the adjoint variables are obtained by 
differentiation of the Hamiltonian function, evaluated at the optimal control. 
Then the adjoint system can be written as
\begin{gather*}
  - \frac{d\lambda_{S_h}}{dt}=  \frac{\partial H}{\partial S_h}
= -[(1-u_1)\beta\varepsilon_h\phi I_v + \mu_h]\lambda_{S_h}  
+ (1-u_1)\beta\varepsilon_h\phi I_v\lambda_{E_h}  \\
 - \frac{d\lambda_{E_h}}{dt}=  \frac{\partial H}{\partial E_h}
= -(\mu_h + \alpha_h)\lambda_{E_h}  + \alpha_h\lambda_{I_h} 
\\
\begin{aligned}
 - \frac{d\lambda_{I_h}}{dt}= \frac{\partial H}{\partial I_h}
&= m - [ (b+u_2)+ (\mu_h + \psi)]\lambda_{I_h} + (b+u_2)\lambda_{R_h} \\
&\quad + (1-u_1)\lambda\varepsilon_v\phi S_v(\lambda_{E_v}-\lambda_{S_v}) 
\end{aligned}\\
 - \frac{d\lambda_{R_h}}{dt}=  \frac{\partial H}{\partial R_h}
= \kappa\lambda_{S_h}  - (\mu_h + \kappa)\lambda_{R_h} 
+ (1-u_1)\lambda\varepsilon_v\phi\eta S_v(\lambda_{S_v}-\lambda_{E_v}) 
\\
\begin{aligned}
 - \frac{d\lambda_{S_v}}{dt}=  \frac{\partial H}{\partial S_v}
& = - [(1-u_1)\lambda\varepsilon_v\phi(I_h+\eta R_h) + u_3(1-p) 
 + \mu_v]\lambda_{S_v} \\
&\quad + (1-u_1)\lambda\varepsilon_v\phi(I_h+\eta R_h)\lambda_{E_v} 
\end{aligned}\\
 - \frac{d\lambda_{E_v}}{dt}=  \frac{\partial H}{\partial E_v}
= -[ u_3(1-p)+ \alpha_v + \mu_v]\lambda_{E_v}  + \alpha_v\lambda_{I_v}  \\
\begin{aligned}
 - \frac{d\lambda_{I_v}}{dt}= \frac{\partial H}{\partial I_v}
&= -(1-u_1)\beta\varepsilon_h\phi S_h\lambda_{S_h} 
 + (1-u_1)\beta\varepsilon_h\phi S_h\lambda_{E_h} \\
&\quad - [u_3(1-p)+  \mu_v ]\lambda_{I_v}
\end{aligned}
\end{gather*}
with transversality conditions
\begin{equation}
 \lambda_{S_h}(t_f)=\lambda_{E_h}(t_f)=~\lambda_{I_h}(t_f)
=\lambda_{R_h}(t_f)=\lambda_{S_v}(t_f)=\lambda_{E_v}(t_f)=\lambda_{I_v}(t_f)=0
\label{eT1}
\end{equation}
On the interior of the control set, where $0<u_i<1$, for $i=1,2,3$, we have
\begin{equation}
\begin{gathered}
0= \frac{\partial H}{\partial u_1}= 2nu_1^* +\beta\varepsilon_h\phi I^*_v
 (\lambda_{S_h} - \lambda_{E_h}) S^*_h
 + \lambda\varepsilon_v\phi (I^*_h+\eta R^*_h)(\lambda_{S_v} - \lambda_{E_v}) S^*_v,\\
0= \frac{\partial H}{\partial u_2}=   2cu_2^*  -(\lambda_{I_h}  
 - \lambda_{R_h} )I_h^*,\\
0= \frac{\partial H}{\partial u_3}= 2du_3^* -(1-p)(S_v^*\lambda_{S_v} 
+ E_v^*\lambda_{E_v } + I_v^*\lambda_{I_v}).
\end{gathered}
\end{equation}
Hence, we obtain (see \cite{Len})
\begin{gather*}
u^*_1=  \frac{ \beta\varepsilon_h\phi I^*_v(\lambda_{E_h} 
 - \lambda_{S_h}) S^*_h+ \lambda\varepsilon_v\phi (I^*_h+\eta R^*_h)(\lambda_{E_v} 
 - \lambda_{S_v}) S^*_v }{2n},\\ 
u^*_2=  \frac{ (\lambda_{I_h}  - \lambda_{R_h} )I_h^* }{2c}, \\ 
u^*_3= \frac{ (1-p)(S_v^*\lambda_{S_v} + E_v^*\lambda_{E_v } 
+ I_v^*\lambda_{I_v}) }{2d}.
\end{gather*}
and
\begin{gather*}
 u^*_1 = \max\Big\{0,\min\Big(1, \frac{ \beta\varepsilon_h\phi I^*_v(\lambda_{E_h} 
 - \lambda_{S_h}) S^*_h+ \lambda\varepsilon_v\phi (I^*_h+\eta R^*_h)(\lambda_{E_v} 
 - \lambda_{S_v}) S^*_v }{2n}\Big)\Big\}, \\
 u^*_2 = \max\Big\{0,\min\Big(1, \frac{ (\lambda_{I_h}  
 - \lambda_{R_h} )I_h^* }{2c}\Big)\Big\}\\
u^*_3 = \max\Big\{0,\min\Big(1,~\frac{  (1-p)(S_v^*\lambda_{S_v} + E_v^*\lambda_{E_v } 
 + I_v^*\lambda_{I_v}  ) }{2d}\Big)\Big\}\,.
 \end{gather*}%\label{eC1}
\end{proof}

Due to the a priori boundedness of the state and adjoint functions and the resulting 
Lipschitz structure of the ODE's, we can obtain the uniqueness of the optimal
 control for small $t _{f}$, following techniques from \cite {Pon}.
The uniqueness of the optimal control follows from the uniqueness of the 
optimality system, which consists of \eqref{eM12} and \eqref{eA}, \eqref{eT} 
with characterization \eqref{eC}. There is a restriction on the length
of time interval in order to guarantee the uniqueness of the optimality system.
This smallness restriction of the length on the time is due to the opposite time 
orientations of the optimality system;
the state problem has initial values and the adjoint problem has final values. 
This restriction is very common in
control problems (see \cite{Jo, Ki,Le1}).


Next we discuss the numerical solutions of the optimality system and the 
corresponding optimal control pairs, the parameter choices, and the 
interpretations from various cases.

\section{Numerical results} \label{num}

In this section, we study numerically an optimal transmission parameter control for 
the malaria model. The optimal control is obtained by solving the optimality system, 
consisting of 7 ODE's from the state and adjoint equations. 
An iterative scheme is used for solving the optimality system.
We start to solve the state equations with a guess for the controls over the 
simulated time using fourth order Runge-Kutta scheme. Because of
the transversality conditions \eqref{eT}, the adjoint equations are solved by
a backward fourth order Runge-Kutta scheme using the current iterations solutions 
of the state equation. Then the controls are updated by using a
convex combination of the previous controls and the value from the 
characterizations \eqref{eC}.
This process is repeated and iterations are stopped if the values of the unknowns
 at the previous iterations are very close to the ones at the present 
iterations \cite{Len}.

We explore a simple model with preventive and treatment as control measures 
to study the effects of control practices and the transmission of malaria. 
Using various combinations of the three controls, one control at a time and
 two controls at a time, we investigate and compare numerical results from
simulations with the following scenarios

\begin{itemize}
\item[i.] using personal protection $(u_1)$ without insecticide spraying
 $(u_3=0)$ and no treatment of the symptomatic humans $(u_2 = 0)$

\item[ii.] treating the symptomatic humans $(u_2)$ without using insecticide 
spraying $(u_3=0)$ and no personal protection $(u_1 = 0)$,

\item[iii.] using insecticide spraying $(u_3)$ without personal protection
 $(u_1 = 0)$ and no treatment of the symptomatic humans $(u_2 = 0)$,

\item[iv.] treating the symptomatic humans $(u_2)$ and using insecticide 
spraying $(u_3)$ with no personal protection $(u_1 = 0)$,

\item[v.] using personal
protection $(u_1)$ and insecticide spraying $(u_3)$ with no treatment of 
the symptomatic humans $(u_2 = 0)$,

\item[vi] using treatment $(u_2)$ and personal protection $(u_1)$ with no 
insecticide
spraying $(u_3 = 0)$, finally

\item[vii.] using all three control measures ($u_1$, $u_2$ and $ u_3$).

\end{itemize}


\begin{table}[Ht]
 \footnotesize
\caption{Description of Variables and Parameters of the Malaria 
Model \eqref{eM12}}
\label{p1}
\begin{center}
\begin{tabular}{llll}\hline \hline
Var.&Description \\\hline\hline 
$S_h$	& Susceptible human\\
$E_h$	& Exposed human\\
$I_h$	& Infected human\\
$R_h$	& Recovered human\\
$S_v$	& Susceptible vector\\
$E_v$	& Exposed vector\\
$I_v$	& Infected vector\\
\hline \hline

Par. &Description&Est. val.&References\\
\hline \hline
$\varepsilon_h$ & biting rate of humans & 0.2-0.5 & \cite{Ari,Isa}\\
$\varepsilon_v$ & biting rate of mosquitoes & 0.3 & \cite{Isa,Mbo,Sno}\\
$\beta$& probability of human getting infected&0.03& \cite{Fla,DLS}\\
%$\beta_2$& probability of a vaccinated human getting infected&0.01& \cite{KYH}\\
$\lambda$ & probability of a mosquito getting infected & 0.09& \cite{Fla,DLS}\\
$\mu_h$& Natural death rate in humans& 0.0004& \cite{Hyun2}\\
$\mu_v$& Natural death rate in mosquitoes& 0.04& \cite{chi}\\
$\kappa$ & rate of loss of immunity & 1/(2$\times$365)& \cite{ARM, Fla,Rui}\\
$\alpha_1$& rate of progression from exposed  to infected human& 1/17& \cite{ARM,Mol}\\
$\alpha_2$& rate of progression from exposed  to infected mosquito& 1/18& \cite{She,Sno,Mit}\\
$\Lambda_h$ & human birth rate & 0.00011 & \cite{Us}\\
$\Lambda_v$ & mosquitoes birth rate & 0.071& \cite{ARM,Fla}\\
$\psi$ & disease induced death&0.05& \cite {RJS}\\
$\phi$ & contact rate of vector per human per unit time& 0.6& \cite {chitnis}\\
$b$& spontaneous recovery & 0.005& \cite {chi}\\
$\eta$& modification parameter &0.01& assumed\\ 
\hline \hline
\end{tabular}
\end{center}

\end{table}

For the figures presented here, we assume that the weight factor c associated with 
control $u_2$ is greater than n and d which are associated with controls $u_1$ 
and $u_3$. This assumption is based on the facts that the cost associated with 
$u_1$ and $u_3$ will include the cost of insecticide and insecticide treated bed nets,
 and the cost associated with $u_2$ will include the cost of
antimalarial drugs, medical examinations and hospitalization. For the numerical 
simulation we have used the following weight factors, $ m = 92$, $n = 20$,
$c = 65$, and $d = 10$, initial state variables $S_h(0) =700$, $E_h(0) = 100$,
 $I_h(0) = 0$, $R_h(0) = 0$, $S_v(0) = 5000$, $E_v(0) = 500$, $I_v(0) = 30$ 
and parameter values $\Lambda_v =0.071$, $\Lambda_h =0.00011$,
$\beta = 0.030$, $\varepsilon_h = 0.01$,
$\varepsilon_h = 0.01$, $\lambda = 0.05$, $\mu_h = 0.0000457$,
$\mu_v = 0.0667$, $\kappa =0.0014$, $\alpha_1 = 0.058$, 
$\alpha_2 = 0.0556$, $\sigma = 0.025$, $b = 0.5$, $\phi = 0.502$,
$\psi = 0.02$, $\tau = 0.5$, $p = 0.85$,
for which the reproduction number $R_0 = 4.3845$, to illustrate the effect 
of different optimal control strategies on the spread of malaria in a population. 
Thus, we have considered the
spread of malaria in an endemic population.

\subsection*{Optimal personal protection}

Only the control $(u_1)$ on personal protection is used to
optimize the objective function $J$, while the control on treatment $(u_2)$ and
 the control on insecticide spray $(u_3)$ are set to zero. 
In Figure \ref{fig1}, the results show a significant difference in the $I_h$ and $I_v$
with optimal strategy compared to $I_h$ and $I_v$ without control. 
Specifically, we observed in Figure \ref{fig1}(a) that the control strategies lead
to a decrease in the number of symptomatic human $(I_h)$
as against an increases in the uncontrolled case. 
Similarly, in Figure \ref{fig1}(b), the uncontrolled
case resulted in increased number of infected mosquitoes $(I_v)$, while the 
control strategy lead to a decrease in the number infected. 
The control profile is shown in Figure \ref{fig1}(c),
here we see that the optimal personal protection control $u_1$ is at the upper 
bound till the time
$t_f = 100$ days, before dropping to the lower bound.

\begin{figure}[ht]
\begin{center}
\includegraphics[width=0.45\textwidth]{fig1a}\quad
\includegraphics[width=0.45\textwidth]{fig1b}\\
 (a)\hfil (b)\\
\includegraphics[width=0.45\textwidth]{fig1c}\\
(c)
\end{center}
% {infectedhumanu1.eps}} {infectedmosquitou1.eps}} {controlu1.eps}}
\caption{Simulations showing the effect of personal protection only on infected
human and mosquitoes populations }
\label{fig1}
\end{figure}

\subsection*{Optimal treatment}

With this strategy, only the control $(u_2)$ on treatment is used to
optimize the objective function $J$, while the control on personal protection
 $(u_1)$ and the control on insecticide spray
$(u_3)$ are set to zero. In Figure \ref{fig2}, the results show a significant 
difference in the $I_h$ and $I_v$ 
with optimal strategy compared to $I_h$ and $I_v$ without control. 
But this strategy shows that effective treatment only
has a significant impact in reducing the disease incidence among human 
population. 
The control profile is shown in Figure \ref{fig2}(c),
we see that the optimal treatment control $u_2$ rises to and stabilizes at the 
upper bound for $t_f = 70$ days, before dropping to the lower bound.

\begin{figure}[ht]
\begin{center}
\includegraphics[width=0.45\textwidth]{fig2a}\quad
\includegraphics[width=0.45\textwidth]{fig2b}\\
 (a)\hfil (b)\\
\includegraphics[width=0.45\textwidth]{fig2c}\\
(c)
\end{center}
% {infectedhumanu2.eps}} {infectedmosquitou2.eps}} {controlu2.eps}}
\caption{Simulations showing the effect of treatment only on infected
human and mosquitoes populations }
\label{fig2}
\end{figure}

\subsection*{Optimal insecticide spraying}

With this strategy, only the control on insecticide spraying $(u_3)$ is used to
optimize the objective function $J$, while the control on treatment $(u_2)$ 
and the control on personal protection $(u_1)$ are set to zero. 
The results in Figure \ref{fig3} show a significant difference in the $I_h$ 
and $I_v$
with optimal strategy compared to $I_h$ and $I_v$ without control. 
We see in Figure \ref{fig3}(a) that the control strategies resulted 
in a decrease in the number of symptomatic human $(I_h)$
as against an increase in the uncontrolled case. Also in Figure \ref{fig3}(b),
 the uncontrolled case resulted in increased number of infected 
mosquitoes $(I_v)$, 
while the control strategy lead to a drastic decrease in the number of infected
mosquitoes. The control profile is shown in Figure \ref{fig3}(c),
here we see that the optimal insecticide spray control $u_3$ is at the upper
 bound till the time
$t_f = 90$ days, it then reduces gradually to the lower bound.

\begin{figure}[ht]
\begin{center}
\includegraphics[width=0.45\textwidth]{fig3a}\quad
\includegraphics[width=0.45\textwidth]{fig3b}\\
 (a)\hfil (b)\\
\includegraphics[width=0.45\textwidth]{fig3c}\\
(c)
\end{center}
% {infectedhumanu3.eps}} {infectedmosquitou3.eps}} {controlu3.eps}}
\caption{Simulations showing the effect of insecticide spraying only on infected
human and mosquitoes populations }
\label{fig3}
\end{figure}

\subsection*{Optimal treatment and insecticide spray}

With this strategy, the control $(u_2)$ on treatment and the control on $(u_3)$ 
insecticide spraying are both used to optimize the objective function $J$, while the control on
 personal protection $(u_1)$ is set to zero. 
In Figure \ref{fig4}, the result shows a significant difference in the $I_h$ 
and $I_v$ with optimal control strategy compared to $I_h$ and $I_v$ without control. 
We observed in Figure \ref{fig4}(a) that the control strategies resulted in a 
decrease in the number of symptomatic humans $(I_h)$
as against increases in the uncontrolled case. Similarly in Figure \ref{fig4}(b),
the uncontrolled case resulted in increased number of infected mosquitoes 
$(I_v)$, while the  control strategy lead to a decrease in the number 
of infected mosquitoes. 
The control profile is shown in Figure \ref{fig4}(c), here we see that 
the optimal  treatment control $u_2$ is at the upper bound till
time $t_f = 50$, while 
the optimal insecticide spray $u_3$ is at the upper bound for
90 days before reducing gradually to the lower bound.

\begin{figure}[ht]
\begin{center}
\includegraphics[width=0.45\textwidth]{fig4a}\quad
\includegraphics[width=0.45\textwidth]{fig4b}\\
 (a)\hfil (b)\\
\includegraphics[width=0.45\textwidth]{fig4c}\\
(c)
\end{center}
%{infectedhumanu2u3.eps}} {infectedmosquitou2u3.eps}}{controlu2u3.eps}}
\caption{Simulations showing the effect of treatment and spray of insecticide on
 infected
human and mosquitoes populations }
\label{fig4}
\end{figure}

\subsection*{Optimal personal protection and insecticide spray}

Here, the control on personal protection $(u_1)$ and the spray of insecticide 
$(u_3)$ are used to optimize the objective function 
$J$ while setting the control 
on treatment $u_2 = 0$. For this strategy, shown in Figure \ref{fig5}, we observed 
that the number of symptomatic human $(I_h)$ and mosquitoes $(I_v)$ differs 
considerably from the uncontrolled case. Figure \ref{fig5}(a), reveals
that symptomatic humans $(I_h)$ is lower in comparison with the case without control.
While Figure \ref{fig5}(b), reveals a similar result of decreased number of 
infected mosquitoes $(I_v)$ for the controlled strategy as compared with the 
strategy without control. The control
profile in Figure \ref{fig5}(c) shows that the control on personal protection 
$(u_1)$ is at upper bound for 60 days,
while insecticide spray $(u_3)$ is at upper bound for $t = 100$ days before 
reducing to the lower bound.

\begin{figure}[ht]
\begin{center}
\includegraphics[width=0.45\textwidth]{fig5a}\quad
\includegraphics[width=0.45\textwidth]{fig5b}\\
 (a)\hfil (b)\\
\includegraphics[width=0.45\textwidth]{fig5c}\\
(c)
\end{center}
% {infectedu1u3.eps}} {infectedmosquitou1u3.eps}}{controlu1u3.eps}}
\caption{Simulations showing the effect of optimal personal protection 
and spray of insecticide on infected human and mosquitoes populations}
\label{fig5}
\end{figure}

\subsection*{Optimal personal protection and treatment}

With this strategy, the control on personal protection $(u_1)$ and the treatment 
$(u_2)$ are used to optimize the objective function $J$ while setting the control
 on spray of insecticide $u_3$ to zero. For this strategy, shown in 
Figure \ref{fig6}, there is a significant difference in the
$I_h$ and $I_v$ with optimal strategy compared to $I_h$ and $I_v$ without control.
 We observed in Figure \ref{fig6}(a) that due to the control strategies, the number 
of symptomatic humans $(I_h)$ decreases as against the increase in the uncontrolled 
case. A similar decrease is observed in Figure \ref{fig6}(b) for infected mosquitoes 
$(I_v)$ in the control strategy, while an increased number is observed for the 
uncontrolled case resulted. In Figure \ref{fig6}(c), the control profile,
the control $u_1$ is at the upper bound for 118 (days) and drops gradually until 
reaching the lower bound, while control on treatment $u_2$ starts and remain 
at upper bound for 12 days before dropping gradually to the lower bound. 
The result here shows that with a personal protection coverage of $100\%$ 
for 118 days and treatment coverage of $100\%$ for 12 (days), the
disease incidence will be greatly reduced.

\begin{figure}[ht]
\begin{center}
\includegraphics[width=0.45\textwidth]{fig6a}\quad
\includegraphics[width=0.45\textwidth]{fig6b}\\
 (a)\hfil (b)\\
\includegraphics[width=0.45\textwidth]{fig6c}\\
(c)
\end{center}
%{infectedhumanu1u2.eps}} {infectedmosquitou1u2.eps}} {controlu1u2.eps}}
\caption{Simulations showing the effect of optimal personal protection 
and treatment on infected human and mosquitoes populations}
\label{fig6}
\end{figure}

\subsection*{Optimal personal protection, treatment and insecticide spray}

Here, all three controls ($u_1, u_2$ and $u_3$) are used to optimize the 
objective function $J$, with
weight factors $m = 92$, $n = 20$, $c = 65$, $d = 10$. For this strategy in
 Figure \ref{fig7}, we observed
in Figure \ref{fig7}(a) and \ref{fig7}(b) that the control strategies resulted 
in a decrease in the number of
symptomatic humans $(I_h)$ and infected mosquitoes $(I_v)$ as against the 
increased number of symptomatic humans $(I_h)$ and infected mosquitoes in 
the uncontrolled case. The control
profile shown in Figure \ref{fig7}(c), shows that the control $u_1$ is at 
upper bound for $t_f = 60$ days,
while control $u_2$, starts high at about 77\% and reduces to
the lower bound gradually over time. The control $u_3$ on the other hand 
is at upper bound for about 100 days before reducing to the lower bound.

\begin{figure}[ht]
\begin{center}
\includegraphics[width=0.45\textwidth]{fig7a}\quad
\includegraphics[width=0.45\textwidth]{fig7b}\\
 (a)\hfil (b)\\
\includegraphics[width=0.45\textwidth]{fig7c}\\
(c)
\end{center}
%{infectedhumanu1u2u3.eps}} {infectedmosquitou1u2u3.eps}} {controlu1u2u3.eps}}
\caption{Simulations showing the effect of optimal personal protection,
treatment and spray of insecticide on infected human and mosquitoes populations}
\label{fig7}
\end{figure}


A comparison of all four control strategies in Figures \ref{fig8}(a) and 
\ref{fig8}(b) shows that while all four strategies lead to a decrease in the
 number of infected,  both in human and in mosquitoes.
The control strategy without treatment resulted in a higher number of infected
humans, followed by the strategy without personal protection. The strategy without
 the spray of insecticide even though, it gave a better result in reducing the 
infection in human, gave a poorer result in reducing the mosquitoes population. 
This result shows that with individuals total adherence to effective
use of personal protection and spray of insecticide in the population, 
little treatment efforts will then be required by the community in the control 
of the spread of the disease.

\begin{figure}[ht]
\begin{center}
\includegraphics[width=0.45\textwidth]{fig8a}\quad
\includegraphics[width=0.45\textwidth]{fig8b}\\
 (a)\hfil (b)
\end{center}
%{figure5a.eps}} {figure5b.eps}}
\caption{Simulations showing the Comparison of the effect of the different 
control strategies}
\label{fig8}
\end{figure}

\subsection*{Spray of insecticide}

A scenario with reducing different fraction of vector population is simulated,
 the result shows that the value of $p = 0.2$ gave the lowest number of susceptible
$(S_v)$ vectors while $p = 0.85$ gave the least value of infected $(I_v)$ vectors,
this is followed by $p = 0.6$, $p = 0.85$ and lastly by $p = 1$ 
(a case corresponding to no use or ineffective insecticide) as expected.
This has the resultant effect (not depicted here) on total number of vectors 
susceptible to malaria $S_v$. When $p = 0.85$, the total number of vectors 
susceptible to malaria, $S_v$ is $4900$,
when $p = 0.6$, $S_v = 2000$, and lastly when $p = 0.2$, the total number of 
susceptible vectors
to malaria, $S_v = 1000$.

\subsection{Concluding remarks}
In this paper, we presented a malaria model using a deterministic system 
of differential equations and established that the model is locally 
asymptotically stable when the associated reproduction number is less than unity. 
In the optimal control problem considered, we use one control at a time  and 
the combination of two controls at a time, while setting the other(s) to zero 
to investigate and compare the effects of the control strategies on malaria 
eradication. This is different from what was investigated in \cite{KYH} where 
only two control measures of personal protection and treatment were used while 
varying the vector-host contact rate. Our numerical results shows that the 
combination of the three (3) controls, personal protection, treatment and 
insecticides spray, has the highest impact on the control of the disease. 
This is followed by the combination of treatment and personal protection 
among the human population; and lastly by the combination involving the use 
of personal protection and insecticide use. In communities where resources
 are scarce, we suggest that the combination of treatment and personal 
protection should be adopted, having observed from the comparison of all four
 control strategies in Figure \ref{fig8}, that there is no significant difference
between this strategy and the combination of the three (3) controls. 
Although, our recommendation agrees with the result obtained by Blayneh 
et al\cite{KYH}, our result however shows two possible control strategies, 
each with two combinations of control measures that are sufficient to effectively 
achieve and maintain interruption of transmission of malaria. 
A result which addresses the WHO \cite{WHO3} concern about the insufficiency of 
only one  control measure to achieve and maintain interruption of transmission 
of malaria.

\subsection*{Acknowledgments}
K. O. Okosun acknowledges, with thanks, the support from the South African 
Center for Epidemiological Modeling and Analysis South Africa (SACEMA). 
F.B. Agusto conducted part of this work as a Postdoctoral Fellow 
at NIMBioS, National Institute for Mathematical and Biological 
Synthesis (NIMBioS) is an Institute sponsored by the National Science Foundation,
 the U.S. Department of Homeland Security, and the U.S. Department 
of Agriculture through NSF Award \#EF-0832858, with additional support
 from The University of Tennessee, Knoxville.


\begin{thebibliography}{99}

\bibitem{ABM} Adams, B. M.; Banks, H. T.; Kwon, H.; Tran Hien, T.;  
Dynamic multidrug therapies for HIV: Optimal and STI control approaches,
 \emph{Math. Bio. and Eng.}, \textbf{1} (2) (2004), 223--241.

\bibitem{Agu}  Agusto, F. B.; Gumel, A. B.;
 Theoretical assessment of avian influenza vaccine.  
\emph{DCDS Series B}. \textbf{13} (1)  (2010), 1--25.

\bibitem{ARM} Anderson, R. M.; May, R. M.;
\emph{Infectious Diseases of Humans: Dynamics and Control}, 
Oxford University Press, Oxford, 1991.

\bibitem{Ari} Ariey, F.; Robert, V.;
 The puzzling links between malaria transmission and drug resistance, 
\emph{Trends in Parasitology}, \textbf{19} (2003), 158--160.

\bibitem{KYH} Blayneh, K.; Cao, Y.; Kwon, H.;
 Optimal control of vector-borne diseases: Treatment and Prevention. 
\emph{Discrete and continuous dynamical systems series B}, \textbf{11} (3)  (2009).,
587--611.

\bibitem{BRW} Brown, C. W.; Kahoui, M. E. l.; Novotni, D.; Weber, A.;
 Algorithmic methods for investigating equilibria in epidemic modeling,
\emph{Journal of Symbolic Computation}, \textbf{41}  (2006), 1157--1173.

\bibitem{CEC} Castillo,  C.;
 Optimal control of an epidemic through educational campaigns, 
\emph{Electronic Journal of Differential Equations}, \textbf{2006}, 
no. 125,  1--11.

\bibitem{CDC} Centers for Disease Control and Prevention (CDC) Malaria,
 \\http://www.cdc.gov/malaria/malaria\_worldwide/reduction/itn.html.
 Accessed August 17, 2011. 

\bibitem{chitnis} Chitnis, N.; Cushing, J. M.; Hyman, J. M.; 
 Bifurcation Analysis of a Mathematical model for malaria transmission.
 \emph{SIAM J. Appl. Math.} \textbf{67} (1)  (2006),  24--45.

\bibitem{chi} Chiyaka, C.; Tchuenche, J. M.; Garira, W.; Dube, S.;
A Mathematical analysis of the effects of control strategies on the 
transmission dynamics of Malaria. 
\emph{Applied Mathematics and Computation}, \textbf{195}  (2008), 641--662.

\bibitem{Cov}  Covell, G.;
 Relationship between malaria paresitaemia and symptoms of the disease: 
a review of the literature. \emph{Bulletin of the World Health Organization}.
 \textbf{22}  (1960), 605--619.

\bibitem{Fla} Flahault, A.; Le Menach, A.; McKenzie, E. F.;  Smith, D. L.;
 The unexpected importance of mosquito oviposition behaviour for malaria: 
non-productive larval habitats can be sources for malaria transmissionn.
 \emph{Malaria Journal}, 4.  (2005).

\bibitem{Fl} Fleming, W. H.; Rishel, R. W.;
 Deterministic and Stochastic Optimal Control. Springer Verlag, New York, 1975.

\bibitem {Green} Greenhalgh, D.;
 Some results for an SEIR epidemic model with density dependent in the death rate.
 \emph{IMA, Journal Math Appl. Med. Bio.} \textbf{9}  (1992),  67--106.

\bibitem{Het} Hethcote, H. W.;
  The mathematics of infectious diseases. \emph{SIAM Review}, 
\textbf{42}(4),  (2000), 599--653.

\bibitem{Jo} Joshi, H. R.;
  Optimal Control of an HIV Immunology Model, 
\emph{Optim. Control Appl. Math}, \textbf{23}  (2002), 199--213.

\bibitem{KARRA} Karrakchou, R. M.;  Gourari, S.;
Optimal control and infectiology: Application to an HIV/ AIDS model.
 \emph{Applied Mathematics and Computation}, \textbf{177}   (2006), 807--818.

\bibitem {Isa} Kawaguchi, I.; Sasaki, A.; Mogi, M.;
 Combining zooprophylaxis and insecticide spraying: a malaria-control 
strategy limiting the development of insecticide resistance in vector 
mosquitoes \emph{Proc. R. Soc. Lond.}  \textbf{271}  (2004), 301--309.
 DOI 10.1098/rspb.2003.2575

\bibitem{KWM} Kermack, W. O.; McKendrick, A. G.;
 Contributions to the Mathematical theory of epidemics - II. 
The Problem of endemicity. Bulletin of Mathematical Biolooy \textbf{53} (1/2)  (1991),
 57--87.

\bibitem{Ki} Kirschner, D.; Lenhart, S.; Serbin, S.;
 Optimal Control of the Chemotherapy of HIV. \emph{J. Math. Biol.} \textbf{35}
 (1997), 775--792.

\bibitem{Lak} Lakshmikantham. V.; Leela, S.; Martynyuk, A. A.;
 Stability Analysis of Nonlinear Systems. Marcel Dekker, Inc., 
New York and Basel, 1989.

\bibitem{Le1} Lenhart, S.; Bhat, M. G.;
 Application of Distributed Parameter Control Model in Wildlife Damage Management,
 \emph{Math. Models \& Methods in Appl. Sci.}, \textbf{2} (4) (1992), 423--439.

\bibitem{Len} Lenhart, S.; Workman, J. T.;
 Optimal Control Applied to Biological Models. Chapman and Hall, 2007.

\bibitem{MAC} Macdonald, G.;
 The Epidemiology and Control of Malaria Oxford: Oxford University Press, 1957.

\bibitem{MAL} Malaria Foundation International;
 Malaria: background information, http://www.malaria. org/backgroundinfo.html
(1998).

\bibitem{Mbo}  Mbogob, C. M.; Gu, W.; Killeena, G. F.;
 An individual-based model of plasmodium falciparum malaria transmission
 on the coast of kenya, \emph{Transactions of the Royal Society of Tropical 
Medicine and Hygiene}. \textbf{97}  (2003), 43--50.

\bibitem{Mit} Mitchell, V. S.; Oaks, Jr. S. C.; Pearson, G. W.;
 Malaria: Obstacles and Opportunities, National Academy Press, Washington, DC
 (1991).

\bibitem{Mol} Molineaux, L.; Gramiccia, G.;
 The Garki Project, World Health Organization,  (1980).

\bibitem{oko} Okosun, K.;
\emph{Mathematical epidemiology of Malaria disease transmission and its optimal 
control analyses}. PhD thesis, University of the Western Cape, South Africa, 2010.

\bibitem{Pon} Pontryagin, L. S.; Boltyanskii, V. G.;
 Gamkrelidze, R. V.;  Mishchenko, E. F.;
 The mathematical theory of optimal processes, Wiley, New York, 1962.

\bibitem{rafi} Rafikov, M.; Bevilacqua, L.; Wyse, A. P. P.;
 Optimal control strategy of malaria vector using genetically modified mosquitoes. 
\emph{J. Theoretical Biology}, \textbf{258}  (2009), 418--425.

\bibitem{Ros} Rosenberg, R.;  Andre, R. G.;  Ketrangse, S.;
 Seasonal fluctuation of Plasmodium falciparum gametocytaemia. 
\emph{Transactions of The Royal Society of Tropical Medicine and Hygiene}, 
\textbf{84}  (1990), 29--33.

\bibitem{ROSS} Ross R,;
 \emph{The prevention of malaria}, 2nd edition. London: Murray. 1911.

\bibitem{Rui}   Ruiz, D.; Poveda, G.; Vlez, I. D. etal; 
 Modelling entomological-climatic interactions of
\emph{plasmodium falciparum} malaria transmission in two colombian 
endemic-regions: contributions to a national malaria early warning system. 
 \emph{Malaria Journal}, \textbf{5} (66)  (2006).

\bibitem{She}  Sherman, I. W.;
 Malaria: Parasite Biology, Pathogenesis, and Protection, 
AMS Press, Washington, DC  (1998).

\bibitem {DLS} Smith, D. L.; McKenzie, F. E.;
 Statics and dynamics of malaria infection in Anopheles mosquitoes. 
\emph{Malaria Journal},  \textbf{3}  (2004),  13 doi: 10.1186/1475-2875-3-13.

\bibitem {RJS}  Smith, R. J.; Hove-Musekwa, S. D.;
 Determining effective spraying periods to control malaria via indoor 
residual spraying in sub-saharan Africa. 
\emph{J. Applied Mathematics and Decision Sciences}. Article ID 745463,
 (2008).

\bibitem{Sno}  Snow, R. W.; Omumbo, J.;
 Malaria, in Diseases and Mortality in Sub-Saharan Africa,
 D. T. et al Jamison, ed., The World Bank.  (2006), 195--213.

\bibitem{SUPS} Suresh, P. S.;
 Optimal Quarantine programmes for controlling an epidemic spread,
 \emph{Journal Opl. Res. Soc.} \textbf{29} (3)  (1978), 265--268.

\bibitem{Tho} Thom\'e, R. C. A.; Yang, H. M.;  Esteva, L.;
 Optimal control of Aedes aegypti mosquitoes by the sterile insect technique
and insecticide.  \emph{Mathematical Biosciences}, \textbf{223}  (2010), 12--23.

\bibitem{Us}  U.S. Census Bureau, International database, 2007.

\bibitem{van} Van den Driessche P.; Watmough J.;
Reproduction numbers and sub-threshold endemic equilibria for compartmental 
models of disease transmission. \emph{Mathematical Biosciences}, \textbf{180}
 (2002),  29-48.

\bibitem{WHO} WHO; Malaria, fact sheets, http://www.who.int/inf-fs/en/fact094.html
 (1998).

\bibitem{WHO3} WHO; Global Malaria Programme: Position Statement on ITNs,
(2009).

\bibitem{WICK} Wickwire, K.;
 A note on the optimal control of carrier - borne epidemic. 
\emph{J. Applied probability},  \textbf{12}  (1975),  565--568.

\bibitem{XIE} Yan, X.; Zou, Y.; Li, J.;
 Optimal quarantine and isolation strategies in epidemics control.
 \emph{World Journal of Modelling and Simulation}, \textbf{3} (3)  (2007),
202--211.

\bibitem {Hyun2} Yang, H. M.;
 A mathematical model for malaria transmission relating global warming 
and local socioeconomic conditions. \emph{Rev. Saude Publica}, \textbf{35} (3)
(2001), 224--231.

\end{thebibliography}


\end{document}






